JP2003096029A - Optically active alcohol and method for producing the same - Google Patents

Optically active alcohol and method for producing the same

Info

Publication number
JP2003096029A
JP2003096029A JP2001288387A JP2001288387A JP2003096029A JP 2003096029 A JP2003096029 A JP 2003096029A JP 2001288387 A JP2001288387 A JP 2001288387A JP 2001288387 A JP2001288387 A JP 2001288387A JP 2003096029 A JP2003096029 A JP 2003096029A
Authority
JP
Japan
Prior art keywords
substituted
optically active
ifo
genus
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001288387A
Other languages
Japanese (ja)
Other versions
JP4913296B2 (en
Inventor
Eiji Sato
栄治 佐藤
Noriyuki Komatsu
範之 小松
Ryuichi Endo
隆一 遠藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Rayon Co Ltd
Original Assignee
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Rayon Co Ltd filed Critical Mitsubishi Rayon Co Ltd
Priority to JP2001288387A priority Critical patent/JP4913296B2/en
Publication of JP2003096029A publication Critical patent/JP2003096029A/en
Application granted granted Critical
Publication of JP4913296B2 publication Critical patent/JP4913296B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a new optically active alcohol and optically active m-nitro- substituted-1-phenetyl alcohol derivative, which are important at raw materials of pharmaceuticals or agrochemicals and also to provide methods of producing the same. SOLUTION: The method of producing an optically active m-nitro- substituted-1-phenetyl alcohol derivative comprises contacting a m-nitro- substituted-2-halogen-substituted-acetophenone with microbacteria, culture supernatants or treated material thereof which can transform a m-nitro- substituted-acetophenone into a m-nitro-substituted-1-phenetyl alcohol derivative, and collecting the optically active m-nitro-substituted-1-phenetyl alcohol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、医農薬品等の原料
として重要な新規光学活性アルコール、光学活性m−ニ
トロ基置換−1−フェネチルアルコール誘導体およびそ
れらの製造方法に関する。
TECHNICAL FIELD The present invention relates to a novel optically active alcohol, an optically active m-nitro group-substituted-1-phenethyl alcohol derivative which is important as a raw material for medicines and agricultural chemicals, and a method for producing them.

【0002】[0002]

【従来の技術】医薬、農薬などの分野において、光学異
性体間に著しい生理活性の相違があることが認識され、
近年、光学活性体の重要性が益々高まっている。このよ
うな状況を踏まえ、種々の光学活性中間体の開発が望ま
れている。これまでに、ラセミ体2−ハロゲン置換−1
−(m−ニトロフェニル)アルコール誘導体についての
製造例が報告されている(CA53;276a)。しかし、その
光学活性体について未だ合成された例は知られていな
い。また、特開平9−289897号公報には光学活性
p位ニトロ基置換−1−フェネチルアルコール誘導体の
合成の可能性を示唆する記載があるが、m位ニトロ基置
換体については同公報の製法で製造可能か否かは全く不
明であった。
2. Description of the Related Art In the fields of medicine, agricultural chemicals, etc., it has been recognized that there are remarkable differences in physiological activity among optical isomers,
In recent years, the importance of optically active substances has been increasing. Under such circumstances, development of various optically active intermediates is desired. So far, racemic 2-halogen substitution-1
A production example of a-(m-nitrophenyl) alcohol derivative has been reported (CA53; 276a). However, there is no known synthetic example of the optically active substance. Further, Japanese Patent Application Laid-Open No. 9-289897 discloses a possibility of synthesizing an optically active p-position nitro group-substituted-1-phenethyl alcohol derivative, but the m-position nitro group-substituted product can be prepared by the method of the same publication. It was completely unknown whether it could be manufactured.

【0003】一方、微生物を利用してケトン体から光学
活性なアルコールを得る方法、即ち酵素不斉還元技術を
用いた光学活性中間体の合成法については以前より検討
が行われている。例えば、前記反応にはパン酵母を代表
とする微生物が最もよく用いられている。また、近年、
種々のケトン体から、光学活性なアルコールを合成する
方法が開発されている(例えば有機合成協会誌Vol.59,6
59-669(2001))。しかし、開示された化合物が限定され
た化合物のみで未だ充分とは言えない。その中でも、Te
trahedron,Vol.54,13059-13072(1998)には、光学活性p
位ニトロ基置換−1−フェネチルアルコール誘導体の酵
素不斉還元による合成法が報告されている。しかし、m
位ニトロ基置換体については何ら記載されていない。す
なわち、酵素反応の性格上、極めて高い基質選択的ゆえ
に、現状では、m位置換体に応用できうるか全くわから
ないのが現状であった。
On the other hand, a method for obtaining an optically active alcohol from a ketone body by utilizing a microorganism, that is, a method for synthesizing an optically active intermediate using an enzyme asymmetric reduction technique has been previously studied. For example, microorganisms represented by baker's yeast are most often used in the above reaction. In recent years,
A method for synthesizing an optically active alcohol from various ketone bodies has been developed (for example, Journal of Organic Synthesis Vol. 59, 6).
59-669 (2001)). However, it cannot be said that the disclosed compounds are only limited compounds. Among them, Te
trahedron, Vol.54,13059-13072 (1998) has optical activity p
A synthetic method by enzymatic asymmetric reduction of a nitro group-substituted 1-phenethyl alcohol derivative has been reported. But m
Nothing is described about the substituted nitro group. That is, because of the extremely high substrate selectivity due to the nature of the enzymatic reaction, at present it was not known at all whether it could be applied to the m-position substitution product.

【0004】[0004]

【発明が解決しようとする課題】したがって、本発明
は、医農薬品等の原料として重要且つ新規な光学活性ア
ルコール、光学活性m−ニトロ基置換−1−フェネチル
アルコール誘導体およびそれらの製造方法を提供するこ
とを目的とする。
Therefore, the present invention provides an important and novel optically active alcohol, an optically active m-nitro group-substituted-1-phenethyl alcohol derivative as a raw material for medicines and agricultural chemicals, and a method for producing them. The purpose is to do.

【0005】[0005]

【課題を解決するための手段】本発明者らは、新規な光
学活性アルコールを開発すべく鋭意検討を行った結果、
酵素不斉還元により、新規な光学活性アルコールを製造
できることを新たに見出し、本発明を完成させるに至っ
た。
Means for Solving the Problems As a result of earnest studies to develop a novel optically active alcohol, the present inventors have found that
The inventors have newly found that a novel optically active alcohol can be produced by enzymatic asymmetric reduction, and completed the present invention.

【0006】すなわち、本発明は、一般式1(式中、X
はハロゲン原子を示す)で示される光学活性アルコー
ル、(R)−2−ハロゲン置換−1−(m−ニトロフェ
ニル)アルコール誘導体、
That is, according to the present invention, the general formula 1 (where X is
Represents a halogen atom), an (R) -2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative,

【化5】 および、一般式2(式中、Xはハロゲン原子を示す)で
示される光学活性アルコール、(S)−2−ハロゲン置
換−1−(m−ニトロフェニル)アルコール誘導体、
[Chemical 5] And an optically active alcohol represented by the general formula 2 (wherein X represents a halogen atom), a (S) -2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative,

【化6】 さらに、一般式3[Chemical 6] Furthermore, the general formula 3

【化7】 (式中、Xはハロゲン原子を示す)で示されるm−ニト
ロ基置換アセトフェノン誘導体を、一般式4
[Chemical 7] (In the formula, X represents a halogen atom), an m-nitro group-substituted acetophenone derivative represented by the general formula 4

【化8】 (式中、Xはハロゲン原子を示し、*は光学活性を表
す。)で示される光学活性m−ニトロ基置換−1−フェ
ネチルアルコール誘導体に変換する能力を有する微生物
菌体又は培養上清若しくはそれらの処理物を上記一般式
3で示されるm−ニトロ基置換2−ハロゲン置換アセト
フェノンに接触せしめ、一般式4の光学活性m−ニトロ
基置換−1−フェネチルアルコール誘導体を採取する光
学活性m−ニトロ基置換−1−フェネチルアルコール誘
導体の製造方法である。
[Chemical 8] (In the formula, X represents a halogen atom and * represents optical activity.) Microorganism cells or culture supernatants or those having the ability to be converted into an optically active m-nitro group-substituted-1-phenethyl alcohol derivative The optically active m-nitro for collecting the optically active m-nitro group-substituted-1-phenethyl alcohol derivative of the general formula 4 by contacting the treated product of the above with the m-nitro group-substituted 2-halogen-substituted acetophenone represented by the above general formula 3. It is a method for producing a group-substituted 1-phenethyl alcohol derivative.

【0007】[0007]

【発明の実施の形態】以下、本発明を詳細に説明する。
一般式1で示される(R)−2−ハロゲン置換−1−
(m−ニトロフェニル)アルコール誘導体、一般式2で
示される(S)−2−ハロゲン置換−1−(m−ニトロ
フェニル)アルコール誘導体、一般式3で示されるm−
ニトロ基置換アセトフェノンおよび一般式4で示される
光学活性m−ニトロ基置換−1−フェネチルアルコール
誘導体において、Xはハロゲン原子を示し、具体的に
は、塩素原子、臭素原子等が例示される。また、一般式
4で示される光学活性m−ニトロ基置換−1−フェネチ
ルアルコール誘導体において、*印は光学活性体である
ことを表す。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below.
(R) -2-halogen-substituted-1-in formula 1
(M-Nitrophenyl) alcohol derivative, (S) -2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative represented by the general formula 2, and m-represented by the general formula 3.
In the nitro group-substituted acetophenone and the optically active m-nitro group-substituted-1-phenethyl alcohol derivative represented by the general formula 4, X represents a halogen atom, and specific examples thereof include a chlorine atom and a bromine atom. Further, in the optically active m-nitro group-substituted-1-phenethyl alcohol derivative represented by the general formula 4, * indicates that it is an optically active substance.

【0008】原料となる一般式3で示されるm−ニトロ
基置換アセトフェノン誘導体はm−ニトロアセトフェノ
ンを定法によりハロゲン化することで合成可能である
(例えばJ.Pharm.Sci.,Vol.56,28-32,1967,)。本発明
において使用する一般式3で示されるm−ニトロ基置換
アセトフェノンを一般式4で示される光学活性2−ハロ
ゲン置換−1−(m−ニトロフェニル)アルコール誘導
体に不斉還元する能力を有する微生物は、本反応を触媒
し、一般式4で示される光学活性2−ハロゲン置換−1
−(m−ニトロフェニル)アルコール誘導体を製造する
能力を有する微生物菌体又は培養上清若しくはそれらの
菌体処理物であればその種類及び起源を問わない。
The m-nitro group-substituted acetophenone derivative represented by the general formula 3 as a raw material can be synthesized by halogenating m-nitroacetophenone by a conventional method (for example, J. Pharm. Sci., Vol. 56, 28. -32,1967,). A microorganism having the ability to asymmetrically reduce the m-nitro group-substituted acetophenone represented by the general formula 3 used in the present invention to the optically active 2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative represented by the general formula 4. Is an optically active 2-halogen-substituted-1 represented by the general formula 4, which catalyzes this reaction.
The type and origin of the microorganism may be any, as long as it is a microbial cell having the ability to produce a-(m-nitrophenyl) alcohol derivative, a culture supernatant, or a treated product of these cells.

【0009】一般に、本反応を触媒する微生物は、以下
の方法によって見出すことができる。適当な培地、例え
ば、グリセロール30g/L、酵母エキス10g/L、ペプ
トン5g/L 、KH2PO4 11g/LおよびK2HPO4
3g/Lの組成からなる培地またはポテトデキスロース培
地(Difco社製)を殺菌後、微生物を植え、20℃〜
40℃で2日間〜1週間振とう培養する。その後、菌体を
遠心分離等の手段により集菌し、0.1〜1.0%の一
般式3で示されるm−ニトロ基置換アセトフェノンを含
むリン酸緩衝液に適宜懸濁し、2〜3日間30℃で振と
う反応する。その際、還元型ニコチンアミドアデニンジ
ヌクレオチド(NADH)及び/又は還元型ニコチンア
ミドアデニンジヌクレオチドリン酸(NADPH)及び
/又はグルコースを含んだ反応液を用いることで反応の
進行を促進することができる。
Generally, the microorganism which catalyzes this reaction can be found by the following method. Suitable medium such as glycerol 30 g / L, yeast extract 10 g / L, peptone 5 g / L, KH 2 PO 4 11 g / L and K 2 HPO 4.
After sterilizing a medium having a composition of 3 g / L or a potato dexulose medium (manufactured by Difco), planting a microorganism at 20 ° C
Incubate with shaking at 40 ° C for 2 days to 1 week. Thereafter, the cells are collected by a means such as centrifugation, suspended in a phosphate buffer containing 0.1-1.0% of m-nitro group-substituted acetophenone represented by the general formula 3, and then suspended for 2-3 times. React with shaking at 30 ° C for a day. At that time, the progress of the reaction can be promoted by using a reaction solution containing reduced nicotinamide adenine dinucleotide (NADH) and / or reduced nicotinamide adenine dinucleotide phosphate (NADPH) and / or glucose. .

【0010】さらに、集菌された菌体をアセトン処理又
は真空乾燥により乾燥したものを用いることも反応を促
進させる場合がある。反応終了後の反応液は、酢酸エチ
ル等の有機溶媒で抽出し、生成した一般式4の光学活性
m−ニトロ基置換−1−フェネチルアルコール誘導体を
高速液体クロマトクロマトグラフィー(カラム:ダイセ
ル化学工業株式会社製 Chiralcel OD)又はガスクロマ
トグラフィー(カラム:クロムパック社製 CP-Chirasi
l DEX CB 0.25mmID X 25M)により分析し、その光学純
度および収率を測定する。この手法により、本反応を触
媒する微生物を見出すことが可能である。
Further, the reaction may also be promoted by using the collected bacterial cells dried by acetone treatment or vacuum drying. The reaction solution after completion of the reaction is extracted with an organic solvent such as ethyl acetate, and the produced optically active m-nitro group-substituted-1-phenethyl alcohol derivative of the general formula 4 is subjected to high performance liquid chromatography (column: Daicel Chemical Industries Ltd.). Company Chiralcel OD) or gas chromatography (column: Chrompack CP-Chirasi)
DEX CB 0.25mmID X 25M) to determine its optical purity and yield. By this method, it is possible to find microorganisms that catalyze this reaction.

【0011】<高速液体クロマトクロマトグラフィー分
析条件> カラム;ダイセル化学工業株式会社製 Chiralcel OD 移動層;イソプロパノール/n−ヘキサン=10:90 流速;1.0ml/min. 検出;245nm 溶出順序;R体、S体の順で溶出される。
<High-performance liquid chromatographic analysis conditions> Column: Chiralcel OD mobile bed manufactured by Daicel Chemical Industries, Ltd .; Isopropanol / n-hexane = 10: 90 Flow rate; 1.0 ml / min. Detection: 245 nm Elution order: R form and S form are eluted in this order.

【0012】<ガスクロマトグラフィー分析条件> カラム:クロムパック社製 CP-Chirasil DEX CB 0.25m
mID X 25M 注入温度;230℃ 検出温度;230℃ キャリアーガス;ヘリウム カラム温度;180℃ 検出;FID 溶出順序;S体、R体の順で溶出される。
<Gas chromatography analysis conditions> Column: CP-Chirasil DEX CB 0.25m manufactured by Chrompack
mID X 25M injection temperature; 230 ° C detection temperature; 230 ° C carrier gas; helium column temperature; 180 ° C detection; FID elution order; S form and R form are eluted in this order.

【0013】そのような微生物としては、特に制限はな
いが、代表的なものとして、アブシディア(Absidia)
属、アスペルギルス(Aspergillus)属、オウレオバシ
ディーム(Aureobasidium)属、ブラケセレア(Blakesl
ea)属、ボトリヨティニア(Botryotinia)属、カルダ
リオマイセス(Caldariomyces)属、セファロアスカス
(Cephaloascus)属、カエトミィーム(Chaetomium)
属、クーニングハメレラ(Cunninghamella) 属、ディ
ポダスカス(Dipodascus)属、 エンドマイセス(Endom
yces)属、ガラクトマイセス(Galactomyces)属、 ゲ
オトリカム(Geotrichum)属、ジベレラ(Gibberella)
属、ヘリコステリューム(Helicostylum)属、ルーコス
ポリディーム(Leucosporidium)属、モルティレラ(Mo
rtierella)属、ムコール(Mucor)属、ニューロスポラ
(Neurospora)属、ペニシリウム(Penicillium)属、
フィコマイセス(Phycomyces)属、ピシオシス(Pythio
psis)属、リゾプス(Rhizopus)属、スシタリディーム
(Scytalidium)属、シネファラストラム(Syncephalas
trum)属、サーモマイセス(Thermomyces)属、トリコ
デルマ(Trichoderma)属、トリコセシーム(Trichothe
cium)属、バートシリューム(Verticillium)属および
ジゴリンガス(Zygorhynchus)属等に属する微生物が挙
げられる。
[0013] Such microorganisms are not particularly limited, but as a representative one, Absidia
Genus, Aspergillus genus, Aureobasidium genus, Blakesl
ea), Botryotinia, Caldariomyces, Cephaloascus, Chaetomium
Genus, Cunninghamella genus, Dipodascus genus, Endomyces (Endom
yces), galactomyces (Galactomyces), geotrichum (Geotrichum), Gibberella (Gibberella)
Genus, Helicostylum, Leucosporidium, Mortillera
rtierella genus, Mucor genus, Neurospora genus, Penicillium genus,
Phycomyces, Pythiosis
psis), Rhizopus, Scytalidium, and Synephalas
genus trum, Thermomyces genus, Trichoderma genus, Trichothesea
cium) genus, Vertillium (Verticillium) genus and digoringus (Zygorhynchus) genus and the like.

【0014】アブシディア(Absidia)属に属する微生
物としては、例えば、Absidia atrospora IFO 9471、Ab
sidia glauca IFO 4002、Absidia glauca IFO 4003およ
びAbsidia spinosa IFO 5873等が、アスペルギルス(As
pergillus)属に属する微生物としては、例えば、Asper
gillus flavus IFO 5324、Aspergillus niger IAM 3008
およびAspergillus sojae IAM 2703等が、オウレオバシ
ディーム(Aureobasidium)属に属する微生物として
は、例えば、Aureobasidium pullulans IFO 4464等が、
ブラケセレア(Blakeslea)属に属する微生物として
は、例えば、Blakesleatrispora IFO 5989等が、ボトリ
ヨティニア(Botryotinia)属に属する微生物として
は、例えば、Botryotinia fuckeliana IAM 5126等が、
カルダリオマイセス(Caldariomyces)属に属する微生
物としては、例えば、Caldariomyces fumago ATCC 1192
5等が、セファロアスカス(Cephaloascus)属に属する
微生物としては、例えば、Cephaloascus albidus IFO 3
0596等が、カエトミィーム(Chaetomium)属に属する微
生物としては、例えば、Chaetomium semispirale IFO 8
363等が、クーニングハメレラ(Cunninghamella)属に
属する微生物としては、例えば、Cunninghamella echin
ulata var.elegans IFO 4446およびCunninghamella ech
inulate IFO 6334等が、ディポダスカス(Dipodascus)
属に属する微生物としては、例えば、Dipodascus aggre
gatus IFO 10816、Dipodascus ambrosiae IFO 10801、D
ipodascus australiensis IFO 10805、Dipodascus capi
tatus IFO 10819、Dipodascus capitatus IFO 10820、D
ipodascus capitatus IFO 1197、Dipodascus geniculat
us IFO 10806、Dipodascus macrosporus IFO 10807、Di
podascusmagnusii IFO 10808、Dipodascus magnusii IF
O 110、Dipodascus magnusii IFO4600、Dipodascus mag
nusii JCM 6360、Dipodascus magnusii JCM 6868、Dipo
dascus ovetensis IFO 1201、Dipodascus ovetensis JC
M 6358、Dipodascus spicifer IFO 10809およびDipodas
cus tetrasperma IFO 10810等が、エンドマイセス(End
omyces)属に属する微生物としては、例えば、Endomyce
s decipiens IFO 0102等が、ガラクトマイセス(Galact
omyces)属に属する微生物としては、例えば、Galactom
yces citri-aurantii IFO 10821、Galactomyces geotri
chum JCM 1945、Galactomyces geotrichum JCM 6359、G
alactomyces reessii IFO 10823およびGalactomyces re
essii JCM 1942等が、ゲオトリカム(Geotrichum)属に
属する微生物としては、例えば、Geotrichum armillari
ae JCM 2454、Geotrichumcandidum IFO 4597、Geotrich
um capitatum JCM 3908、Geotrichum eriense JCM391
2、Geotrichum fermentans JCM 2467、Geotrichum ferm
entans JCM 2468、Geotrichum fragrans JCM 1749、Geo
trichum klebahnii JCM 3913およびGeotrichum rectang
ulatum JCM 1750等が、ジベレラ(Gibberella)属に属
する微生物としては、例えば、Gibberella fujikuroi I
FO 5268等が、ヘリコステリューム(Helicostylum)属
に属する微生物としては、例えば、Helicostylum nigri
cans IFO 8091等が、ルーコスポリディーム(Leucospor
idium)属に属する微生物としては、例えば、Leucospor
idium scotti IFO 9474等が、モルティレラ(Mortierel
la)属に属する微生物としては、例えば、Mortierella
humicola IFO 8188およびMortierella isabellina IFO
7824等が、ムコール(Mucor)属に属する微生物として
は、例えば、Mucor javanicus IFO 4572等が、ニューロ
スポラ(Neurospora)属に属する微生物としては、例え
ば、Neurospora crassa IFO 6067およびNeurospora sit
ophila IFO 6069等が、ペニシリウム(Penicillium)属
に属する微生物としては、例えば、Penicillium caresc
ens IFO 7108およびPenicillium citrium IAM 7008等
が、フィコマイセス(Phycomyces)属に属する微生物と
しては、例えば、Phycomyces nitens IFO 9422等が、ピ
シオシス(Pythiopsis)属に属する微生物としては、例
えば、Pythiopsis cymosa ATCC 26880等が、リゾプス
(Rhizopus)属に属する微生物としては、例えば、Rhiz
opus microsporus IFO 4767およびRhizopus microsporu
s IFO 4768等が、スシタリディーム(Scytalidium)属
に属する微生物としては、例えば、Scytalidium flavob
runneum JCM 6268、Scytalidium infestans IFO 32370
およびScytalidium terminale IFO 6396等が、シネファ
ラストラム(Syncephalastrum)属に属する微生物とし
ては、例えば、Syncephalastrum racemosum IFO 4816等
が、サーモマイセス(Thermomyces)属に属する微生物
としては、例えば、Thermomyces lanuginosus IFO 9738
等が、トリコデルマ(Trichoderma)属に属する微生物
としては、例えば、Trichoderma longibrachiatum IFO
4847およびTrichoderma viride IFO 5720等が、トリコ
セシーム(Trichothecium)属に属する微生物として
は、例えば、Trichothecium roseum IFO 4839等が、バ
ートシリューム(Verticillium)属に属する微生物とし
ては、例えば、Verticillium fungicola IFO 30616等
が、ジゴリンガス(Zygorhynchus)属に属する微生物と
しては、例えば、Zygorhynchus exponens var.smithiiI
FO 6665等が例示される。
The microorganisms belonging to the genus Absidia include, for example, Absidia atrospora IFO 9471, Ab.
sidia glauca IFO 4002, Absidia glauca IFO 4003 and Absidia spinosa IFO 5873 etc.
Examples of microorganisms belonging to the genus pergillus include Asper
gillus flavus IFO 5324, Aspergillus niger IAM 3008
And Aspergillus sojae IAM 2703 and the like, as a microorganism belonging to the genus Aureobasidium (Aureobasidium), for example, Aureobasidium pullulans IFO 4464 and the like,
Examples of the microorganisms belonging to the genus Brakeserea (Blakeslea) include Blakesleatrispora IFO 5989 and the like, and examples of the microorganisms belonging to the genus Botryotinia include Botryotinia fuckeliana IAM 5126 and the like.
Examples of the microorganism belonging to the genus Caldariomyces include Caldariomyces fumago ATCC 1192.
Examples of microorganisms belonging to the genus Cephaloascus include Cephaloascus albidus IFO 3
Examples of the microorganisms belonging to the genus Chaetomium, such as 0596, include Chaetomium semispirale IFO 8
Examples of the microorganisms belonging to the genus Cunninghamella, such as 363, include Cunninghamella echin.
ulata var.elegans IFO 4446 and Cunninghamella ech
inulate IFO 6334 etc. are Dipodascus
Examples of microorganisms belonging to the genus include Dipodascus aggre
gatus IFO 10816, Dipodascus ambrosiae IFO 10801, D
ipodascus australiensis IFO 10805, Dipodascus capi
tatus IFO 10819, Dipodascus capitatus IFO 10820, D
ipodascus capitatus IFO 1197, Dipodascus geniculat
us IFO 10806, Dipodascus macrosporus IFO 10807, Di
podascus magnusii IFO 10808, Dipodascus magnusii IF
O 110, Dipodascus magnusii IFO4600, Dipodascus mag
nusii JCM 6360, Dipodascus magnusii JCM 6868, Dipo
dascus ovetensis IFO 1201, Dipodascus ovetensis JC
M 6358, Dipodascus spicifer IFO 10809 and Dipodas
cus tetrasperma IFO 10810 etc.
Examples of microorganisms belonging to the genus omyces) include Endomyce
s decipiens IFO 0102 etc.
Examples of the microorganism belonging to the genus omyces) include Galactom.
yces citri-aurantii IFO 10821, Galactomyces geotri
chum JCM 1945, Galactomyces geotrichum JCM 6359, G
alactomyces reessii IFO 10823 and Galactomyces re
Examples of microorganisms belonging to the genus Geotrichum, such as essii JCM 1942, include Geotrichum armillari.
ae JCM 2454, Geotrichumcandidum IFO 4597, Geotrich
um capitatum JCM 3908, Geotrichum eriense JCM391
2, Geotrichum fermentans JCM 2467, Geotrichum ferm
entans JCM 2468, Geotrichum fragrans JCM 1749, Geo
trichum klebahnii JCM 3913 and Geotrichum rectang
Examples of microorganisms belonging to the genus Gibberella, such as ulatum JCM 1750, include Gibberella fujikuroi I
FO 5268 and the like are, for example, Helicostylum nigri as microorganisms belonging to the genus Helicostylum.
The cans IFO 8091 etc.
Examples of microorganisms belonging to the genus (idium) include Leucospor
idium scotti IFO 9474 etc.
Examples of microorganisms belonging to the genus la) include Mortierella
humicola IFO 8188 and Mortierella isabellina IFO
7824 and the like are examples of microorganisms belonging to the genus Mucor, for example, Mucor javanicus IFO 4572, and examples of microorganisms belonging to the genus Neurospora, such as Neurospora crassa IFO 6067 and Neurospora sit.
Examples of microorganisms belonging to the genus Penicillium, such as ophila IFO 6069, include Penicillium caresc
ens IFO 7108 and Penicillium citrium IAM 7008 and the like, as microorganisms belonging to the genus Phycomyces, for example, Phycomyces nitens IFO 9422 and the like, as microorganisms belonging to the genus Pythiopsis, for example, Pythiopsis cymosa ATCC 26880 and the like. , Microorganisms belonging to the genus Rhizopus include, for example, Rhiz
opus microsporus IFO 4767 and Rhizopus microsporu
Examples of the microorganisms belonging to the genus Scytalidium, such as s IFO 4768, include Scytalidium flavob
runneum JCM 6268, Scytalidium infestans IFO 32370
And Scytalidium terminale IFO 6396 and the like, as a microorganism belonging to the genus Synephalastrum (Syncephalastrum), for example, Syncephalastrum racemosum IFO 4816 and the like, as a microorganism belonging to the genus Thermomyces (Thermomyces), for example, Thermomyces lanuginosus IFO 9738
Examples of the microorganisms belonging to the genus Trichoderma include Trichoderma longibrachiatum IFO.
4847 and Trichoderma viride IFO 5720 and the like are, for example, Trichothecium roseum IFO 4839 and the like as microorganisms belonging to the genus Trichothecium (Trichothecium), and microorganisms that belong to the genus Verticillium include, for example, Verticillium fungicola IFO 30616 and the like. , As a microorganism belonging to the genus Digoringus (Zygorhynchus), for example, Zygorhynchus exponens var.smithiiI
FO 6665 and the like are exemplified.

【0015】なお、IFO、JCM、IAMおよびAT
CCにより番号が付された菌株は、財団法人 発酵研究
所、理化学研究所 微生物系統保存施設、東京大学 分
子細胞生物学研究所およびアメリカンタイプカルチャー
コレクションから入手することができる。また、これら
の微生物から単離した酵素遺伝子を各種宿主ベクター系
に導入した遺伝子操作微生物の利用も可能である。
Incidentally, IFO, JCM, IAM and AT
The strains numbered by CC can be obtained from the Fermentation Research Institute, RIKEN microbial strain preservation facility, Institute of Molecular and Cellular Biology, University of Tokyo, and American Type Culture Collection. It is also possible to use genetically engineered microorganisms in which enzyme genes isolated from these microorganisms are introduced into various host vector systems.

【0016】本発明において、これらの微生物を培養す
るための培地としては、通常これらの微生物が生育し得
るものであれば何れのものでも使用できる。炭素源とし
ては、例えば、グルコース、シュークロースやマルトー
ス等の糖類、酢酸、クエン酸やフマル酸等の有機酸ある
いはその塩、エタノールやグリセロール等のアルコール
類等を使用できる。窒素源としては、例えば、ペプト
ン、肉エキス、酵母エキスやアミノ酸等の一般天然窒素
源の他、各種無機、有機酸アンモニウム塩等が使用でき
る。その他、無機塩、微量金属塩、ビタミン等が必要に
応じて適宜添加される。また、高い酵素活性を得るため
に、例えば、アセトフェノン等のケトン基あるいはカル
ボニル基を持つ化合物等を酵素産生の誘導物質として培
地に添加することが有効である場合がある。その培養は
常法に従って行えばよく、例えば、pH4〜10、温度
15〜40℃の範囲にて好気的に6時間〜10日間培養
する。また、静置培養で同様に培養することで高い酵素
活性を得ることができる場合がある。
In the present invention, as a medium for culturing these microorganisms, any medium can be used so long as these microorganisms can normally grow. As the carbon source, for example, glucose, sugars such as sucrose and maltose, organic acids such as acetic acid, citric acid and fumaric acid or salts thereof, alcohols such as ethanol and glycerol can be used. As the nitrogen source, for example, in addition to general natural nitrogen sources such as peptone, meat extract, yeast extract and amino acid, various inorganic and organic acid ammonium salts can be used. In addition, inorganic salts, trace metal salts, vitamins and the like are added as needed. In order to obtain high enzyme activity, it may be effective to add a compound having a ketone group or a carbonyl group such as acetophenone to the medium as an enzyme production inducer. The culture may be performed according to a conventional method, for example, aerobically culturing for 6 hours to 10 days at a pH of 4 to 10 and a temperature of 15 to 40 ° C. In addition, it may be possible to obtain a high enzyme activity by similarly culturing in static culture.

【0017】このようにして得られた微生物は、培地中
で培養して得られる培養物をそのままか若しくは該培養
物から遠心分離等の集菌操作によって得られる微生物菌
体又は培養上清、さらにはそれらの処理物の形で、一般
式3で示されるm−ニトロ基置換2−ハロゲン置換アセ
トフェノンと接触せしめ、一般式4の光学活性m−ニト
ロ基置換−1−フェネチルアルコール誘導体を採取する
ことにより、光学活性m−ニトロ基置換−1−フェネチ
ルアルコール誘導体製造することができる。
The microorganism thus obtained is a culture obtained by culturing in a medium as it is, or a microbial cell or a culture supernatant obtained by a harvesting operation such as centrifugation from the culture, and In the form of a treated product thereof is contacted with an m-nitro group-substituted 2-halogen-substituted acetophenone represented by the general formula 3 to collect an optically active m-nitro group-substituted-1-phenethyl alcohol derivative of the general formula 4. Thus, an optically active m-nitro group-substituted-1-phenethyl alcohol derivative can be produced.

【0018】該処理物としては、変換反応を触媒する活
性を示す限り、その使用形態は特に限定されず、乾燥菌
体、アセトン等で処理した菌体、菌体の破砕物、菌体を
破砕した無細胞抽出物、粗酵素、精製酵素等が挙げられ
る。
The treated product is not particularly limited in its form of use as long as it exhibits an activity to catalyze the conversion reaction, and it is a dried bacterial cell, a bacterial cell treated with acetone or the like, a crushed bacterial cell, or a crushed bacterial cell. Cell-free extract, crude enzyme, purified enzyme and the like.

【0019】微生物菌体、菌体培養液、それらの処理物
を反応に供するに際しては、これらを適当な担体に固定
化して用いることができる。例えば、架橋したアクリル
アミドゲル、多糖類などで包括したり、イオン交換樹
脂、珪藻土、セラミックなどの固体担体に物理的、化学
的に固定化することができる。固定化して用いることに
より、触媒活性が上昇する場合があるばかりではなく、
反応終了後の触媒の分離/回収およびその再利用が容易
になる。さらに、通常これら触媒は1種類用いるが、同
様な能力を有する2種以上のそれを混合して用いること
も可能である。
When the microbial cells, the cell culture solution, or a treated product thereof is subjected to the reaction, these can be immobilized on a suitable carrier before use. For example, it can be entrapped with a crosslinked acrylamide gel, a polysaccharide, or the like, or physically or chemically immobilized on a solid support such as an ion exchange resin, diatomaceous earth, or a ceramic. By immobilizing and using, not only the catalytic activity may increase,
Separation / recovery of the catalyst and its reuse after the reaction are facilitated. Furthermore, usually, one kind of these catalysts is used, but it is also possible to mix and use two or more kinds of catalysts having the same ability.

【0020】本発明において、不斉還元反応による一般
式4の光学活性2−ハロゲン置換−1−(m−ニトロフ
ェニル)アルコール誘導体の生産は、以下の方法で行う
ことができる。必要に応じて補酵素(NADH、NAD
PH、NAD及び/又はNADP)及び/又はグル
コース、シュークロース、エタノール、メタノール等の
エネルギー源の存在下、水又は緩衝液等の反応溶媒中で
一般式3のm−ニトロ基置換アセトフェノン誘導体に上
記の微生物菌体、菌体培養液、菌体処理物あるいはこれ
ら微生物により生産される酵素等を接触させることによ
り行うことができる。そして、反応温度、必要により反
応液のpHを制御しながら反応を行う。場合によっては
反応の途中で反応基質(m−ニトロ基置換アセトフェノ
ン又はその塩)及び/又は前記補酵素、エネルギー源を
適宜加え、反応を継続させてもよい。補酵素(NAD
H、NADPH、NAD、NADP)及び/又はグ
ルコース、シュークロース、エタノール、メタノール等
のエネルギー源等を加えることで目的化合物の収率が向
上する場合が多い。
In the present invention, the production of the optically active 2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative of the general formula 4 by the asymmetric reduction reaction can be carried out by the following method. If necessary, coenzymes (NADH, NAD
PH, NAD + and / or NADP + ) and / or m-nitro group-substituted acetophenone derivative of the general formula 3 in a reaction solvent such as water or a buffer solution in the presence of an energy source such as glucose, sucrose, ethanol or methanol. It can be carried out by contacting the above-mentioned microbial cells, microbial cell culture solution, treated microbial cells or enzymes produced by these microorganisms. Then, the reaction is performed while controlling the reaction temperature and, if necessary, the pH of the reaction solution. Depending on the case, the reaction substrate (m-nitro group-substituted acetophenone or a salt thereof) and / or the coenzyme and the energy source may be appropriately added during the reaction to continue the reaction. Coenzyme (NAD
In many cases, the yield of the target compound is improved by adding an energy source such as H, NADPH, NAD + , NADP + ) and / or glucose, sucrose, ethanol or methanol.

【0021】反応液の基質濃度は、0.01〜50質量
%の間で特に制限はないが、生産性等を考慮すると0.
05〜30質量%が好ましい。反応液中の微生物菌体等
の濃度は、通常、0.001〜20質量%であり、好ま
しくは0.005〜10質量%である。反応液のpHは
用いる酵素の至適pH等を考慮し、総合的に決定され、
特に制限はないが、一般的にはpH4〜11の範囲であ
り、好ましくはpH5〜9である。また、反応が進行す
るに従いpHが変化してくる場合があるが、この場合は
適当なpH調整剤この場合は適当な中和剤、例えば、水
酸化ナトリウム、水酸化カリウム、塩酸、硫酸水溶液等
を添加して最適pHに調整することが望ましい。
The substrate concentration of the reaction solution is not particularly limited within the range of 0.01 to 50% by mass, but it is 0.
05-30 mass% is preferable. The concentration of microbial cells and the like in the reaction solution is usually 0.001 to 20% by mass, preferably 0.005 to 10% by mass. The pH of the reaction solution is comprehensively determined in consideration of the optimum pH of the enzyme to be used,
There is no particular limitation, but it is generally in the range of pH 4 to 11, preferably pH 5 to 9. In addition, the pH may change as the reaction proceeds. In this case, a suitable pH adjusting agent, in this case, a suitable neutralizing agent, for example, sodium hydroxide, potassium hydroxide, hydrochloric acid, an aqueous sulfuric acid solution, etc. It is desirable to add to adjust the pH to optimum.

【0022】反応温度は用いる触媒の至適温度によって
適宜決定されるもので特に制限はないが、0〜60℃が好
ましく、5〜50℃がより好ましい。反応溶媒は、通常イ
オン交換水、緩衝液等の水性媒体を使用するが、m−ニ
トロ基置換アセトフェノン誘導体あるいはその塩の溶解
を促進させるために有機溶媒あるいは界面活性剤を含ん
だ系でも反応を行うことができる。有機溶媒としては、
例えば、メタノール、エタノール、プロパノール、イソ
プロパノール、ブタノール、イソブタノール、t-ブチル
アルコール、t-アミルアルコール等のアルコール系溶
媒、ペンタン、ヘキサン、ヘプタン、オクタン等の脂肪
族炭化水素系溶媒、ベンゼン、トルエン、キシレン等の
芳香族炭化水素系溶媒、塩化メチレン、クロロホルム、
四塩化炭素、ジクロロエタン等のハロゲン化炭化水素系
溶媒、ジエチルエーテル、ジイソプロピルエーテル、テ
トラヒドロフラン、ジオキサン等のエーテル系溶媒、酢
酸エチル、酢酸プロピル、酢酸ブチル等のエステル系溶
媒、アセトン、メチルエチルケトン、メチルイソブチル
ケトン等のケトン系溶媒、その他アセトニトリル、N,
N−ジメチルホルムアミド等を適宜使用できる。
The reaction temperature is appropriately determined depending on the optimum temperature of the catalyst used and is not particularly limited, but is preferably 0 to 60 ° C, more preferably 5 to 50 ° C. As the reaction solvent, an aqueous medium such as ion-exchanged water or a buffer is usually used, but the reaction may be carried out even in a system containing an organic solvent or a surfactant to accelerate the dissolution of the m-nitro group-substituted acetophenone derivative or its salt. It can be carried out. As an organic solvent,
For example, methanol, ethanol, propanol, isopropanol, butanol, isobutanol, t-butyl alcohol, alcohol solvents such as t-amyl alcohol, pentane, hexane, heptane, aliphatic hydrocarbon solvents such as octane, benzene, toluene, Aromatic hydrocarbon solvents such as xylene, methylene chloride, chloroform,
Halogenated hydrocarbon solvents such as carbon tetrachloride and dichloroethane, ether solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran and dioxane, ester solvents such as ethyl acetate, propyl acetate and butyl acetate, acetone, methyl ethyl ketone and methyl isobutyl ketone. Ketone-based solvent, such as acetonitrile, N,
N-dimethylformamide or the like can be used as appropriate.

【0023】界面活性剤としては、例えば、アルキルベ
ンゼンスルホン酸塩、アルキル硫酸塩等のアニオン界面
活性剤、アルキルピリジニウム塩、ドデシルトリメチル
アンモニウムクロリド等のカチオン界面活性剤、ポリオ
キシエチレンアルキル(フェニル)エーテル、ポリオキ
シエチレンアルキル(フェニル)エステル、ソルビタン
脂肪酸エステル(スパン系界面活性剤)、ポリオキシエ
チレングリコールソルビタンアルキルエステル(トゥイ
ーン系界面活性剤)、ポリオキシエチレングリコールp
−t−オクチルフェニルエーテル(トリトン系界面活性
剤)、ショ糖脂肪酸エステル等の非イオン性界面活性
剤、N−アルキル−N,N−ジメチルアンモニウムベタ
イン、レシチン、ホスファチジルエタノールアミン、リ
ゾレシチン等の両性界面活性剤等を適宜使用できる。
Examples of the surface active agent include anionic surface active agents such as alkylbenzene sulfonates and alkyl sulfates, cationic surface active agents such as alkylpyridinium salts and dodecyltrimethylammonium chloride, polyoxyethylene alkyl (phenyl) ethers, Polyoxyethylene alkyl (phenyl) ester, sorbitan fatty acid ester (span surfactant), polyoxyethylene glycol sorbitan alkyl ester (tween surfactant), polyoxyethylene glycol p
-N-alkyl-N, N-dimethylammonium betaine, lecithin, phosphatidylethanolamine, lysolecithin, and other amphoteric interfaces such as -t-octylphenyl ether (triton-based surfactant) and sucrose fatty acid ester. Activators and the like can be used as appropriate.

【0024】また、これらの有機溶媒あるいは界面活性
剤を水への溶解度以上に加えて2層系で反応を行うこと
も可能である。有機溶媒を反応系に共存させることで、
選択率、変換率、収率などが向上することも多い。反応
時間は、通常、1時間〜10日間、好ましくは3時間〜
1週間であり、そのような時間で反応が終了する反応条
件を選択することが好ましい。
It is also possible to add these organic solvents or surface active agents in excess of the solubility in water to carry out the reaction in a two-layer system. By allowing an organic solvent to coexist in the reaction system,
The selectivity, conversion rate, yield, etc. often improve. The reaction time is usually 1 hour to 10 days, preferably 3 hours to
It is one week, and it is preferable to select reaction conditions at which the reaction ends at such time.

【0025】尚、以上のような基質濃度、補酵素濃度、
酵素濃度、pH、温度、溶媒、反応時間及びその他の反
応条件はその条件における反応収率等を考慮して目的と
する光学活性2−ハロゲン置換−1−(m−ニトロフェ
ニル)アルコール誘導体が最も多く採取できる条件を適
宜選択することが望ましい。
The above substrate concentration, coenzyme concentration,
Regarding the enzyme concentration, pH, temperature, solvent, reaction time and other reaction conditions, the objective optically active 2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative is most suitable in consideration of the reaction yield under the conditions. It is desirable to appropriately select the conditions that allow many samples to be collected.

【0026】反応終了混合液からの目的物の単離は除菌
後、濃縮、抽出、蒸留、カラム分離または結晶化等通常
の公知の方法によって行うことができる。例えば、必要
に応じてpHを調整後、ジエチルエーテル、ジイソプロ
ピルエーテル等のエーテル類、酢酸エチル等のエステル
類、ヘキサン、ベンゼン、トルエン等の炭化水素類、塩
化メチレン等のハロゲン化炭化水素類、ブタノール、イ
ソブタノール、t-アミルアルコール等のアルコール系溶
媒等一般的な溶媒により抽出分離することができる。
The desired product can be isolated from the reaction-terminated mixed solution by sterilization, and then by a commonly known method such as concentration, extraction, distillation, column separation or crystallization. For example, after adjusting the pH as necessary, ethers such as diethyl ether and diisopropyl ether, esters such as ethyl acetate, hydrocarbons such as hexane, benzene and toluene, halogenated hydrocarbons such as methylene chloride and butanol. It can be separated by extraction with a general solvent such as an alcoholic solvent such as isobutanol, t-amyl alcohol and the like.

【0027】[0027]

【実施例】以下、本発明を実施例により具体的に説明す
る。 <実施例1>グリセロール30g/L、酵母エキス10g/
L、ペプトン5g/L、KH2PO4 11g/LおよびK2
PO4 3g/Lからなる培地10mlを試験管に分注し、
121℃、15分間加熱滅菌した後、表1に示す菌株を
接種し、30℃で2〜7日間振とう培養した。培養終了
後、遠心分離にて集菌した。
EXAMPLES The present invention will be specifically described below with reference to examples. <Example 1> Glycerol 30 g / L, yeast extract 10 g / L
L, peptone 5 g / L, KH 2 PO 4 11 g / L and K 2 H
Dispense 10 ml of medium consisting of 3 g / L of PO 4 into a test tube,
After heat sterilization at 121 ° C. for 15 minutes, the strains shown in Table 1 were inoculated and shake cultured at 30 ° C. for 2 to 7 days. After completion of the culture, the cells were collected by centrifugation.

【0028】集菌した菌体に0.1M HEPES(4
−(2−ヒドロキシエチル)−1−ピペラジンエタンス
ルホン酸)1ml、NADH 3.4mg、10%2−
クロロ−m−ニトロアセトフェノンを含む酢酸エチル溶
液10μlを加え、30℃で24時間反応させた。
[0028] 0.1M HEPES (4
-(2-Hydroxyethyl) -1-piperazineethanesulfonic acid) 1 ml, NADH 3.4 mg, 10% 2-
10 μl of an ethyl acetate solution containing chloro-m-nitroacetophenone was added, and the mixture was reacted at 30 ° C. for 24 hours.

【0029】反応終了後、同量に酢酸エチルを加え、2
−クロロ−1−(m−ニトロフェニル)エタノールで抽
出した。芒硝で抽出液を乾燥後、ガスクロマトグラフィ
ー(カラム;CP-Chirasil DEX CB 0.25mmID X 25M ,ク
ロムパック社製)で生成物である2−クロロ−1−(m
−ニトロフェニル)エタノールの光学純度を測定した。
結果を表1に示す。
After the reaction was completed, ethyl acetate was added to the same amount and 2
Extracted with -chloro-1- (m-nitrophenyl) ethanol. After drying the extract with Glauber's salt, the product 2-chloro-1- (m) was obtained by gas chromatography (column; CP-Chirasil DEX CB 0.25mmID X 25M, manufactured by Chrompack).
The optical purity of -nitrophenyl) ethanol was measured.
The results are shown in Table 1.

【0030】[0030]

【表1】 [Table 1]

【0031】<実施例2>ポテトデキスロース培地(Di
fco社製)10mlを試験管に分注し、121℃、15
分間加熱滅菌した後、表2に示す菌株を接種し、30℃
で2〜7日間振とう培養した。培養終了後、遠心分離に
て集菌した。実施例1と同様に反応及び分析を行い、生
成物である2−クロロ−1−(m−ニトロフェニル)エ
タノールの光学純度を測定した。結果を表2に示す。
<Example 2> Potato dextrose medium (Di
10 ml (made by fco) was dispensed into a test tube, 121 ° C, 15
After heat sterilization for 30 minutes, inoculate the strains shown in Table 2 at 30 ° C
The cells were shake-cultured for 2 to 7 days. After completion of the culture, the cells were collected by centrifugation. Reaction and analysis were carried out in the same manner as in Example 1, and the optical purity of the product 2-chloro-1- (m-nitrophenyl) ethanol was measured. The results are shown in Table 2.

【0032】[0032]

【表2】 [Table 2]

【0033】<実施例3>グリセロール30g/L、酵母
エキス10g/L、ペプトン5g/L 、KH2PO411g/
LおよびK2HPO4 3g/Lからなる培地10mlを試
験管に分注し、121℃、15分間加熱滅菌した後、表
3に示す菌株を接種し、30℃で2〜7日間振とう培養
した。培養終了後、遠心分離にて集菌した。菌体をアセ
トンで3回洗浄し、アセトン処理菌体とした。
<Example 3> Glycerol 30 g / L, yeast extract 10 g / L, peptone 5 g / L, KH 2 PO 4 11 g /
10 ml of a medium consisting of L and K 2 HPO 4 3 g / L was dispensed into a test tube, sterilized by heat at 121 ° C. for 15 minutes, inoculated with the strains shown in Table 3, and shake cultured at 30 ° C. for 2 to 7 days. did. After completion of the culture, the cells were collected by centrifugation. The bacterial cells were washed three times with acetone to give acetone-treated bacterial cells.

【0034】5.32mgの2−クロロ−m−ニトロア
セトフェノン、100mM NADH溶液 17.7mg
および0.1M HEPES緩衝液(pH7)1mlに
表1に示すアセトン処理菌体15mgを懸濁させ、30
℃で24時間反応させた。実施例1と同様に分析を行
い、生成物である2−クロロ−1−(m−ニトロフェニ
ル)エタノールの光学純度を測定した。結果を表3に示
す。
5.32 mg of 2-chloro-m-nitroacetophenone, 100 mM NADH solution 17.7 mg
And 15 mg of acetone-treated cells shown in Table 1 were suspended in 1 ml of 0.1 M HEPES buffer (pH 7),
The reaction was carried out at ℃ for 24 hours. Analysis was performed in the same manner as in Example 1 to measure the optical purity of the product 2-chloro-1- (m-nitrophenyl) ethanol. The results are shown in Table 3.

【0035】[0035]

【表3】 [Table 3]

【0036】<実施例4>実施例3と同様の培地200
0mlでGeotrichum candidum IFO 4597を30℃で48時間
振とう培養した。培養終了後、遠心分離にて集菌した。
この湿菌体を同質量の0.04%2−メルカプトエタノ
ールおよび0.1mMジチオトレイトールを含む50m
M HEPES緩衝液(pH7)に懸濁させ、フレンチ
プレス(2000kg/cm2)により2回破砕した。
菌体破砕液を遠心分離し、上清を回収した。その上清に
4%硫酸プロタミン前記50mM HEPES緩衝液溶
液を同量加え、2〜5℃で一晩撹拌した。翌日、生じた
不溶物を遠心分離で除去し、70%飽和まで硫酸アンモニ
ウムを加え、2〜5℃で一晩放置した。得られた沈殿を
遠心分離で回収し、前記50mM HEPES緩衝液に
溶解させ、10mM リン酸緩衝液(pH6.5)で2
〜5℃中、透析した。透析後の硫安分画溶液を5’AM
Pセファロース4B(アマシャム ファルマシア バイ
オテク社製、乾燥質量0.25g)カラムに供した。10m
M リン酸緩衝液(pH6.5)でカラムを洗浄後、同
リン酸緩衝液に0.2mMになるようにNAD+を溶解
させた溶液で溶出させ、活性画分を酵素溶液とした。
<Example 4> The same culture medium 200 as in Example 3
Geotrichum candidum IFO 4597 was cultured in 0 ml at 30 ° C. for 48 hours with shaking. After completion of the culture, the cells were collected by centrifugation.
50 m of the wet cells containing the same mass of 0.04% 2-mercaptoethanol and 0.1 mM dithiothreitol
The cells were suspended in MHEPES buffer (pH 7) and crushed twice with a French press (2000 kg / cm2).
The disrupted cell suspension was centrifuged and the supernatant was collected. The same amount of 4% protamine sulfate 50 mM HEPES buffer solution was added to the supernatant, and the mixture was stirred at 2 to 5 ° C overnight. The next day, the resulting insoluble matter was removed by centrifugation, ammonium sulfate was added to 70% saturation, and the mixture was left overnight at 2 to 5 ° C. The obtained precipitate was recovered by centrifugation, dissolved in the 50 mM HEPES buffer solution, and then dissolved in 10 mM phosphate buffer solution (pH 6.5).
It was dialyzed in ~ 5 ° C. Ammonium sulfate fractionated solution after dialysis is 5'AM
It was applied to a P Sepharose 4B (Amersham Pharmacia Biotech, dry mass 0.25 g) column. 10m
After washing the column with M phosphate buffer (pH 6.5), the column was eluted with a solution containing 0.2 mM of NAD + in the phosphate buffer to elute the active fraction as an enzyme solution.

【0037】5.32mgの2−クロロ−m−ニトロア
セトフェノン、100mM NADH溶液 17.7mg
および0.1M HEPES緩衝液(pH7)0.9m
lに得られた酵素溶液0.1mlを加え、30℃で24
時間反応させた。実施例1と同様に分析を行い、生成物
である2−クロロ−1−(m−ニトロフェニル)エタノ
ールの光学純度を測定したところ、R体99%ee以上で
あった。
5.32 mg of 2-chloro-m-nitroacetophenone, 100 mM NADH solution 17.7 mg
And 0.1M HEPES buffer (pH 7) 0.9m
0.1 ml of the obtained enzyme solution was added to 1 liter, and the mixture was added at
Reacted for hours. When the optical purity of the product 2-chloro-1- (m-nitrophenyl) ethanol was measured by performing the analysis in the same manner as in Example 1, the R isomer was 99% ee or more.

【0038】<実施例5>実施例3と同様の培地200
0mlでDipodascus magnusii JCM 6360を30℃で48時間
振とう培養した。培養終了後、実施例4と同様に透析ま
で処理し、硫安分画溶液を得た。実施例4の酵素溶液の
代わりに硫安分画溶液を用いる以外は同様に反応させ、
2−クロロ−1−(m−ニトロフェニル)エタノールの
光学純度を測定したところ、R体99%ee以上であっ
た。
<Example 5> The same medium 200 as in Example 3
Dipodascus magnusii JCM 6360 was shake-cultured in 0 ml at 30 ° C. for 48 hours. After completion of the culture, dialysis was performed in the same manner as in Example 4 to obtain an ammonium sulfate fractionation solution. The same reaction was performed except that the ammonium sulfate fractionation solution was used in place of the enzyme solution of Example 4,
When the optical purity of 2-chloro-1- (m-nitrophenyl) ethanol was measured, it was R form 99% ee or more.

【0039】<実施例6>実施例3と同様に調整したDi
podascus magnusii JCM 6360株のアセトン粉末100m
gおよびNADH 30mgを0.1M HEPS緩衝液
(pH7)3mlに懸濁および溶解させた後、15mg
の2−クロロ−m−ニトロアセトフェノンを90μlの
メチルアルコールに溶解させたものを加え、30℃で3
日間反応させた。反応終了後、1.5mlの酢酸エチル
で抽出した。この抽出液を実施例1と同様に分析を行
い、生成物である2−クロロ−1−(m−ニトロフェニ
ル)エタノールの光学純度およびその濃度をを測定した
ところ、99%ee以上の、R−2−クロロ−1−(m
−ニトロフェニル)エタノール9.3mgが存在するこ
とが確認できた。
<Example 6> Di prepared in the same manner as in Example 3
100m of acetone powder of podascus magnusii JCM 6360 strain
15 mg of NADH and 30 mg of NADH were suspended and dissolved in 3 ml of 0.1 M HEPS buffer (pH 7).
2-chloro-m-nitroacetophenone dissolved in 90 μl of methyl alcohol was added, and the mixture was mixed at 30 ° C. for 3 days.
Reacted for days. After completion of the reaction, extraction was performed with 1.5 ml of ethyl acetate. This extract was analyzed in the same manner as in Example 1 to determine the optical purity of the product 2-chloro-1- (m-nitrophenyl) ethanol and its concentration. -2-chloro-1- (m
It was confirmed that 9.3 mg of -nitrophenyl) ethanol was present.

【0040】<実施例7>実施例6で得られた2−クロ
ロ−1−(m−ニトロフェニル)エタノールは1H-NMRを
用いたMosher法(J. A. Dale, H. S. Mosher, J. Am. C
hem. Soc.,95,512(1973))により絶対配置を決定した。
以下に、手順と結果を示す。試料を2分割して、一方を
市販のキラル誘導体化試薬(+)-R-メトキシトリフルオロ
メチルフェニル酢酸クロライド((+)-R-MTPA・Cl)によ
りR-MTPAエステルとした。2分割した試料のもう一方を
市販のキラル誘導体化試薬(-)-S-メトキシトリフルオロ
メチルフェニル酢酸クロライド((-)-S-MTPA・Cl)によ
りS-MTPAエステルとした。R-MTPAエステルとS-MTPAエス
テルをそれぞれ、重水素化クロロホルムに溶解して、Va
rian社製フーリエ変換核磁気共鳴(FT-NMR)装置 UNITY
INOVA 500 (1H共鳴周波数499.818MHz)にて室温で1H
NMRスペクトルを測定した。CH2およびCHは以下のように
観測された。
Example 7 The 2-chloro-1- (m-nitrophenyl) ethanol obtained in Example 6 was subjected to Mosher method using 1 H-NMR (JA Dale, HS Mosher, J. Am. C.
hem. Soc., 95, 512 (1973)), the absolute configuration was determined.
The procedure and results are shown below. The sample was divided into two, and one of them was converted into an R-MTPA ester by using a commercially available chiral derivatization reagent (+)-R-methoxytrifluoromethylphenylacetic acid chloride ((+)-R-MTPA · Cl). The other of the two divided samples was made into an S-MTPA ester by using a commercially available chiral derivatization reagent (-)-S-methoxytrifluoromethylphenylacetic acid chloride ((-)-S-MTPA.Cl). Dissolve R-MTPA ester and S-MTPA ester in deuterated chloroform, and
Fourier transform nuclear magnetic resonance (FT-NMR) device UNITY manufactured by rian
INOVA 500 (1 H resonance frequency 499.818MHz) 1 at room temperature H
The NMR spectrum was measured. CH2 and CH were observed as follows.

【0041】〔(+)-R-MTPAエステル1H NMR (499.818MH
z, CDCl3, RT)δ6.156ppm(dd,J=4Hz,8Hz,1H,C
H),3.836(dd,J=8Hz,12Hz,1H,CH2),3.762(d
d,J=4Hz,12Hz,1H,CH2)〕
[(+)-R-MTPA ester 1H NMR (499.818MH
z, CDCl3, RT) δ 6.156ppm (dd, J = 4Hz, 8Hz, 1H, C
H), 3.836 (dd, J = 8Hz, 12Hz, 1H, CH 2), 3.762 (d
d, J = 4Hz, 12Hz, 1H, CH 2 )]

【0042】〔(-)-S-MTPAエステル1H NMR (499.818MH
z, CDCl3, RT)δ6.208ppm(dd,J=5Hz,7Hz,1H,C
H),3.818(dd,J=7Hz,12Hz,1H,CH2),3.756(d
d,J=5Hz,12Hz,1H,CH2)〕
[(-)-S-MTPA ester 1H NMR (499.818MH
z, CDCl3, RT) δ 6.208ppm (dd, J = 5Hz, 7Hz, 1H, C
H), 3.818 (dd, J = 7Hz, 12Hz, 1H, CH 2), 3.756 (d
d, J = 5Hz, 12Hz, 1H, CH 2 )]

【0043】R-MTPAエステルとS-MTPAエステルの1H-NMR
スペクトルのケミカルシフトを比較した結果、試料であ
る2−クロロ−1−(m−ニトロフェニル)エタノール
はR体であることを確認した。
1 H-NMR of R-MTPA ester and S-MTPA ester
As a result of comparing the chemical shifts of the spectra, it was confirmed that the sample 2-chloro-1- (m-nitrophenyl) ethanol was the R-form.

【0044】[0044]

【発明の効果】本発明により、医農薬品等の原料として
重要な新規な光学活性アルコール、光学活性m−ニトロ
基置換−1−フェネチルアルコール誘導体およびそれら
の製造方法が提供される。
INDUSTRIAL APPLICABILITY The present invention provides a novel optically active alcohol, an optically active m-nitro group-substituted-1-phenethyl alcohol derivative important as a raw material for medicines and agricultural chemicals, and a method for producing them.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07M 7:00 Fターム(参考) 4B064 AE01 CA05 CB18 CD12 DA01 DA11 4H006 AA01 AC41 AC81 ─────────────────────────────────────────────────── ─── Continued Front Page (51) Int.Cl. 7 Identification Code FI Theme Coat (Reference) C07M 7:00 F Term (Reference) 4B064 AE01 CA05 CB18 CD12 DA01 DA11 4H006 AA01 AC41 AC81

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 一般式1(式中、Xはハロゲン原子を示
す)で示される(R)−2−ハロゲン置換−1−(m−
ニトロフェニル)アルコール誘導体。 【化1】
1. (R) -2-halogen-substituted-1- (m-) represented by formula 1 (wherein X represents a halogen atom):
Nitrophenyl) alcohol derivative. [Chemical 1]
【請求項2】 一般式1のXが塩素原子である請求項1
記載の(R)−2−ハロゲン置換−1−(m−ニトロフ
ェニル)アルコール誘導体。
2. The X in the general formula 1 is a chlorine atom.
The (R) -2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative described.
【請求項3】 一般式2(式中、Xはハロゲン原子を示
す)で示される(S)−2−ハロゲン置換−1−(m−
ニトロフェニル)アルコール誘導体。 【化2】
3. (S) -2-halogen-substituted-1- (m-) represented by the general formula 2 (wherein X represents a halogen atom).
Nitrophenyl) alcohol derivative. [Chemical 2]
【請求項4】 一般式2のXが塩素原子である請求項3
記載の(S)−2−ハロゲン置換−1−(m−ニトロフ
ェニル)アルコール誘導体。
4. The X in the general formula 2 is a chlorine atom.
The (S) -2-halogen-substituted-1- (m-nitrophenyl) alcohol derivative described.
【請求項5】一般式3 【化3】 (式中、Xはハロゲン原子を示す)で示されるm−ニト
ロ基置換アセトフェノンを、一般式4 【化4】 (式中、Xはハロゲン原子を示し、*は光学活性を表
す。)で示される光学活性m−ニトロ基置換−1−フェ
ネチルアルコール誘導体に変換する能力を有する微生物
菌体又は培養上清若しくはその処理物を、一般式3で示
されるm−ニトロ基置換2−ハロゲン置換アセトフェノ
ンに接触せしめ、上記一般式4の光学活性m−ニトロ基
置換−1−フェネチルアルコールを採取する光学活性m
−ニトロ基置換−1−フェネチルアルコール誘導体の製
造方法。
5. General formula 3 The acetophenone substituted with m-nitro group represented by the formula (wherein X represents a halogen atom) is represented by the following general formula 4 (In the formula, X represents a halogen atom and * represents optical activity.) A microbial cell or a culture supernatant having the ability to be converted into an optically active m-nitro group-substituted-1-phenethyl alcohol derivative or a culture supernatant thereof The treated product is brought into contact with the m-nitro group-substituted 2-halogen-substituted acetophenone represented by the general formula 3 to collect the optically active m-nitro group-substituted-1-phenethyl alcohol of the above general formula 4.
-A method for producing a nitro group-substituted-1-phenethyl alcohol derivative.
JP2001288387A 2001-09-21 2001-09-21 Optically active alcohol and method for producing the same Expired - Fee Related JP4913296B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001288387A JP4913296B2 (en) 2001-09-21 2001-09-21 Optically active alcohol and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001288387A JP4913296B2 (en) 2001-09-21 2001-09-21 Optically active alcohol and method for producing the same

Publications (2)

Publication Number Publication Date
JP2003096029A true JP2003096029A (en) 2003-04-03
JP4913296B2 JP4913296B2 (en) 2012-04-11

Family

ID=19111047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001288387A Expired - Fee Related JP4913296B2 (en) 2001-09-21 2001-09-21 Optically active alcohol and method for producing the same

Country Status (1)

Country Link
JP (1) JP4913296B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007072753A1 (en) * 2005-12-19 2007-06-28 Sumitomo Chemical Company, Limited Process for production of optically active 3-(3-hydroxyphenyl)-2-alkoxypropanoic acid or ester thereof
JP2007533628A (en) * 2003-10-01 2007-11-22 ビーエーエスエフ アクチェンゲゼルシャフト Method for producing 3-methylamino-1- (thien-2-yl) propan-1-ol
CN110760449A (en) * 2019-11-15 2020-02-07 浙江工业大学 Geotrichum galactose ZJPH1810 and application thereof in preparation of (S) -1- (2, 6-dichloro-3-fluorophenyl) ethanol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09135695A (en) * 1995-11-16 1997-05-27 Kawaken Fine Chem Co Ltd Production of (s)-3-alkylphthalide
WO1999034010A1 (en) * 1997-12-29 1999-07-08 Sanyo Shokuhin Co., Ltd. Process for producing optically active alcohols
WO2001017962A1 (en) * 1999-09-03 2001-03-15 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09135695A (en) * 1995-11-16 1997-05-27 Kawaken Fine Chem Co Ltd Production of (s)-3-alkylphthalide
WO1999034010A1 (en) * 1997-12-29 1999-07-08 Sanyo Shokuhin Co., Ltd. Process for producing optically active alcohols
WO2001017962A1 (en) * 1999-09-03 2001-03-15 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533628A (en) * 2003-10-01 2007-11-22 ビーエーエスエフ アクチェンゲゼルシャフト Method for producing 3-methylamino-1- (thien-2-yl) propan-1-ol
JP2011142908A (en) * 2003-10-01 2011-07-28 Basf Se Method for producing 3-methylamino-1-(thien-2-yl)propan-1-ol
WO2007072753A1 (en) * 2005-12-19 2007-06-28 Sumitomo Chemical Company, Limited Process for production of optically active 3-(3-hydroxyphenyl)-2-alkoxypropanoic acid or ester thereof
CN110760449A (en) * 2019-11-15 2020-02-07 浙江工业大学 Geotrichum galactose ZJPH1810 and application thereof in preparation of (S) -1- (2, 6-dichloro-3-fluorophenyl) ethanol

Also Published As

Publication number Publication date
JP4913296B2 (en) 2012-04-11

Similar Documents

Publication Publication Date Title
Bechtold et al. Biotechnological development of a practical synthesis of ethyl (S)-2-ethoxy-3-(p-methoxyphenyl) propanoate (EEHP): over 100-fold productivity increase from yeast whole cells to recombinant isolated enzymes
Fryszkowska et al. Highly enantioselective reduction of β, β-disubstituted aromatic nitroalkenes catalyzed by Clostridium sporogenes
KR100506134B1 (en) Novel carbonyl reductase, gene that encodes the same, and method of utilizing these
JPS61239899A (en) Biotechnological production of optically active alpha-arylalkanoic acid
Poessl et al. Non‐racemic halohydrins via biocatalytic hydrogen‐transfer reduction of halo‐ketones and one‐pot cascade reaction to enantiopure epoxides
Kosjek et al. Efficient production of raspberry ketone via ‘green’biocatalytic oxidation
WO1998040472A2 (en) Carboxylic acid reductase, and methods of using same
Comasseto et al. Biotransformations of ortho-, meta-and para-aromatic nitrocompounds by strains of Aspergillus terreus: Reduction of ketones and deracemization of alcohols
JP4913296B2 (en) Optically active alcohol and method for producing the same
D’Arrigo et al. Chemo-enzymatic synthesis of ethyl (R)-2-hydroxy-4-phenylbutyrate
JP4818507B2 (en) Process for producing optically active 3-quinuclidinol
Wallner et al. Chemo-enzymatic enantio-convergent asymmetric total synthesis of (S)-(+)-dictyoprolene using a kinetic resolution—stereoinversion protocol
Chaves et al. Regio-and enantioselective bioreduction of methyleneketoesters using both polymeric resin and cellulose matrix
KR100739361B1 (en) Process for the production of optically active ?-amino alcohols
KR20040010202A (en) α-Keto acid reductase, method for producing the same, and method for producing optically active α-hydroxy acids using the same
Singh et al. Enantioselective transesterification of (RS)-1-chloro-3-(3, 4-difluorophenoxy)-2-propanol using Pseudomonas aeruginosa lipases
Zhang et al. Bio‐preparation of (R)‐DMPM using whole cells of Pseudochrobactrum asaccharolyticum WZZ003 and its application on kilogram‐scale synthesis of fungicide (R)‐metalaxyl
US20020160398A1 (en) Chlorohydroxyacetone derivative and process for producing optically active chloropropanediol derivative from the same
Thomas et al. LipG9-mediated enzymatic kinetic resolution of racemates: Expanding the substrate-scope for a metagenomic lipase
JPH0739391A (en) Method of enzymatic decomposition of alpha - third carboxylic acid ester
WO2000037666A1 (en) Process for producing (r)-2-hydroxy-1-phenoxypropane derivative
Andreu et al. Use of Saccharomyces cerevisiae as a whole cell system for aldol condensation in organic medium: Study of the factors affecting the biotransformation
EP1433857B1 (en) Process for producing monomer
JP2006232788A (en) Method for producing optically active 2-chloro-3-hydroxyl-3,n-diphenyl-propanoic acid amide
US5834261A (en) Method for the production of chiral vicinal aminoalcohols

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111020

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111125

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120112

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120119

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150127

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150127

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150127

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150127

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150127

Year of fee payment: 3

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

LAPS Cancellation because of no payment of annual fees